Effects of estrogen-related receptor alpha (ERRα) on proliferation and metastasis of human lung cancer A549 cells

Abstract

Estrogen-related receptor alpha (ERRα) plays an important role in the development of hormone-dependent cancers, but its roles in lung cancer remain elusive. The present study was aimed to investigate the effects of ERRα on the proliferation and metastasis of lung cancer A549 cells. The mRNA and protein levels of ERRα were detected in lung cancer A549 and MCF-7 cells and bronchial epithelial BEAS-2B cells by qRT-PCR and Western blotting, respectively. ERRα plasmid transfection and XCT-790 (an inverse agonist of ERRα) were used to up-regulate or down-regulate ERRα expression in A549 cells, respectively. The viability of A549 cells was measured by cell counting kit-8 (CCK-8) and the motility of A549 cells by wound healing assay and Transwell migration/invasion assay. The epithelial markers E-cadherin (E-Cad) and zona occludin-1 (ZO-1), the mesenchymal markers fibronectin (FN) and vimentin (Vim) and the transcription factors (Snail, Zeb1 Twist and Slug) were further detected at mRNA and protein levels by qRT-PCR and Western blotting, respectively. The results showed that ERRα promoted the growth of lung cancer A549 cells in vitro. XCT-790 significantly inhibited the migration and invasion of A549 cells. Over-expression of ERRα promoted the epithelial-to-mesenchymal transition (EMT) of A549 cells, down-regulated the epithelial makers E-Cad and ZO-1, and up-regulated the mesenchymal makers FN and Vim. Silencing of Slug, but not other transcription factors, significantly abolished the ERRα-induced EMT of A549 cells. It was suggested that ERRα promoted the migration and invasion of A549 cells by inducing EMT, and Slug was involved in the process. Targeting ERRα might be an efficient approach for lung cancer treatment.

Keywords

estrogen-related receptor alpha / XCT-790 / migration / invasion / A549 cells

References

[1] GiguereV, YangN, SeguiP, et al. . Identification of a new class of steroid hormone receptors. Nature, 1988, 331(6151): 91-94 PMID: 3267207

[2] LuoJ, SladekR, CarrierJ, et al. . Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha. Mol Cell Biol, 2003, 23(22): 7947-7956 PMCID: 262360 PMID: 14585956

[3] ShayuD, RaoAJ. Expression of functional aromatase in the epididymis: Role of androgens and LH in modulation of expression and activity. Mol Cell Endocrinol, 2006, 249(1–2): 40-50 PMID: 16569475

[4] VanackerJM, DelmarreC, GuoX, et al. . Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alpha. Cell Growth Differ, 1998, 9(12): 1007-1014 PMID: 9869301

[5] DufourCR, WilsonBJ, HussJM, et al. . Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. Cell Metab, 2007, 5(5): 345-356 PMID: 17488637

[6] SteinRA, McDonnellDP. Estrogen-related receptor alpha as a therapeutic target in cancer. Endocr-Relat Cancer, 2006, 13: S25-S32 PMID: 17259555

[7] AriaziEA, KrausRJ, FarrellML, et al. . Estrogen-related receptor alpha1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway. Mol Cancer Res, 2007, 5(1): 71-85 PMID: 17259347

[8] BoudjadiS, BernatchezG, BeaulieuJF, et al. . Control of the human osteopontin promoter by ERRalpha in colorectal cancer. Am J Pathol, 2013, 183(1): 266-276 PMID: 23680656

[9] LamSS, MakAS, YamJW, et al. . Targeting estrogen-related receptor alpha inhibits epithelial-to-mesenchymal transition and stem cell properties of ovarian cancer cells. Mol Ther, 2014, 22(4): 743-751 PMID: 24419103

[10] AriaziEA, ClarkGM, MertzJE. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res, 2002, 62(22): 6510-6518 PMID: 12438245

[11] FujimotoJ, AlamSM, JahanI, et al. . Clinical implication of estrogen-related receptor (ERR) expression in ovarian cancers. J Steroid Biochem Mol Biol, 2007, 104(3–5): 301-304 PMID: 17509876

[12] ChangCY, KazminD, JasperJS, et al. . The metabolic regulator ERRalpha, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer. Cancer Cell, 2011, 20(4): 500-510 PMCID: 3199323 PMID: 22014575

[13] BernatchezG, GirouxV, LassalleT, et al. . ERRalpha metabolic nuclear receptor controls growth of colon cancer cells. Carcinogenesis, 2013, 34(10): 2253-2261 PMID: 23720198

[14] EhemanC, HenleySJ, Ballard-BarbashR, et al. . Annual Report to the Nation on the status of cancer, 1975–2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer, 2012, 118(9): 2338-2366 PMID: 22460733

[15] BouchardyC, BenhamouS, SchaffarR, et al. . Lung cancer mortality risk among breast cancer patients treated with anti-estrogens. Cancer, 2011, 117(6): 1288-1295 PMID: 21264820

[16] Marquez-GarbanDC, ChenHW, FishbeinMC, et al. . Estrogen receptor signaling pathways in human non-small cell lung cancer. Steroids, 2007, 72(2): 135-143 PMID: 17276470

[17] ThieryJP, AcloqueH, HuangRY, et al. . Epithelial-mesenchymal transitions in development and disease. Cell, 2009, 139(5): 871-890 PMID: 19945376

[18] VoulgariA, PintzasA. Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta, 2009, 1796(2): 75-90 PMID: 19306912

[19] CanoA, PeinadoH, OlmedaD. Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer, 2007, 7(6): 415-428 PMID: 17508028

[20] MarinoM, GalluzzoP, AscenziP. Estrogen signaling multiple pathways to impact gene transcription. Curr Genomics, 2006, 7(8): 497-508 PMCID: 2269003 PMID: 18369406

[21] BiancoS, SaillandJ, VanackerJM. ERRs and cancers: Effects on metabolism and on proliferation and migration capacities. J Steroid Biochem Mol Biol, 2012, 130(3–5): 180-185 PMID: 21414406

[22] FujimotoJ, SatoE. Clinical implication of estrogen-related receptor (ERR) expression in uterine endometrial cancers. J Steroid Biochem Mol Biol, 2009, 116(1–2): 71-75 PMID: 19416752

[23] CavalliniA, NotarnicolaM, GianniniR, et al. . Oestrogen receptor-related receptor alpha (ERRalpha) and oestrogen receptors (ERalpha and ERbeta) exhibit different gene expression in human colorectal tumour progression. Eur J Cancer, 2005, 41(10): 1487-1494 PMID: 15949936

[24] CheungCP, YuS, WongKB, et al. . Expression and functional study of estrogen receptor-related receptors in human prostatic cells and tissues. J Clin Endocrinol Metab, 2005, 90(3): 1830-1844 PMID: 15598686

[25] SuzukiT, MikiY, MoriyaT, et al. . Estrogen-related receptor a in human breast carcinoma as a potent prognostic factor. Cancer Res, 2004, 64(13): 4670-4676 PMID: 15231680

[26] WangJ, WangY, WongC. Oestrogen-related receptor alpha inverse agonist XCT-790 arrests A549 lung cancer cell population growth by inducing mitochondrial reactive oxygen species production. Cell Prolif, 2010, 43(2): 103-113 PMID: 20447055

[27] BiancoS, LanvinO, TribolletV, et al. . Modulating estrogen receptor-related receptor-alpha activity inhibits cell proliferation. J Biol Chem, 2009, 284(35): 23286-23292 PMCID: 2749102 PMID: 19546226

[28] XuS, ZhuangX, PanX, et al. . 1-Phenyl-4-benzoyl-1H-1,2,3-triazoles as orally bioavailable transcriptional function suppressors of estrogen-related receptor alpha. J Med Chem, 2013, 56(11): 4631-4640 PMID: 23656512

[29] SteinRA, ChangCY, KazminDA, et al. . Estrogen-related receptor alpha is critical for the growth of estrogen receptor-negative breast cancer. Cancer Res, 2008, 68(21): 8805-8812 PMCID: 2633645 PMID: 18974123

[30] ThieryJP, SleemanJP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol, 2006, 7(2): 131-142 PMID: 16493418